Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Ipca Labs In Focus As Motilal Oswal Remains Bullish After Inline Q4 Results — Check Target Price, Upside
Ipca Labs delivered a steady performance in the March quarter, with Motilal Oswal maintaining its bullish stance, citing strong growth visibility in domestic formulations and export markets.
Asian Paints shares rally 4% after Q4 results. Here’s what Nomura and Motilal Oswal are saying
Asian Paints shares rose sharply after the company reported a 69% year-on-year jump in Q4FY26 profit and stronger margins. While Nomura reiterated its Buy call with a Rs 3,600 target price, Motilal Oswal maintained a Neutral stance, citing demand uncertainties despite raising earnings estimates and growth expectations.
Ashok Leyland Shares In Focus As Motilal Oswal Stays Bullish Despite Near-Term Headwinds — Check Target Price, Upside And More
Ashok Leyland delivered an in-line operational performance for Q4, with Motilal Oswal maintaining a bullish stance on the stock's long-term earnings outlook despite near-term demand uncertainties.
Nifty Midcap 100 hits all-time high even as Sensex, Nifty slide
Midcap stocks outperformed benchmark indices as domestic investors continued to favour the segment despite geopolitical tensions and sustained foreign investor selling
Premier Energies shares in focus as promoters sell stake worth Rs 2,289 crore. Check top buyers
Promoter family members of Premier Energies sold shares worth around Rs 2,289 crore through a block deal, while institutional investors, including Quant Mutual Fund and Nomura, picked up stakes. The development comes amid strong investor interest in renewable energy and domestic solar manufacturing, supported by robust earnings growth and aggressive capacity expansion plans.
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
Zydus LifeSciences Shares in Focus: Motilal Oswal Maintains Neutral Rating on Limited Upside — Check Revised Target Price
The current valuation provides limited upside and hence, Motilal Oswal has maintained Neutral rating on Zydus Lifesciences.
After Nomura, Motilal Oswal also sees gold duty hike manageable for Titan
Motilal Oswal believes Titan is well-equipped to manage the situation through superior gold sourcing capabilities and a strong balance sheet.
Canara HSBC Life In Focus as Motilal Oswal Bets on Multi-Year Compounding Story — Check Target Price, Upside
The differentiated dual-bank partnership with mass scale from Canara Bank and premium affluence from HSBC creates a distribution backbone that only a few private life insurers possess.
Top Gainers & Losers on May 18: Gland Pharma, Coforge, PB Fintech, BSE, Voltas, Bharti Airtel among top gainers
Indian stocks marginally gained on May 18, driven by strong tech buying and pharma support, with Nifty 50 up 0.03% at 23,649 and BSE Sensex at 75,263. However, the broader market faced pressure as Nifty Midcap 100 and Nifty Smallcap 100 fell.
SAIL Shares in Focus After Strong Q4; Motilal Oswal Stays Bullish With Higher Target Price — Check New Upside
SAIl remained in focus after Motilal Oswal reiterated its Buy rating on the stock and revised the target price upward.
JSW Steel and Radico Khaitan top Motilal Oswal's buy list after strong earnings
Siddhartha Khemka, Head of Research, Wealth Management at Motilal Oswal Financial Services, recommends Radico Khaitan (target ₹4,000) and JSW Steel (target ₹1,520) on strong earnings. He backs Adani Ports and Adani Power on volume growth and power demand. On OMCs, he sees limited downside post the ₹3 hike with HPCL as an interesting pick, while gold jewellery stocks may stay under near-term pressure.